Epidemiological and overall survival properties of cutaneous melanomas at Ege University Hospital
Abstract
Aim: We aimed to evaluate the epidemiological and survival characteristics of patients diagnosed as melanoma in the database of Ege University Hospital between 1992-2017.
Materials and Methods: The data of 1530 patients diagnosed with melanoma enrolled at Ege University between 1992-2017, recorded by the CANREG 4 program by specially trained and certified cancer registry staff of the Ege University Cancer Control Research and Application Center, were collected. While the existence of the relationship between categorical variables was evaluated with the Chi-Square method, the numerical variables between the groups were compared with the One Way Variance Analysis and the Turkey HSD Test. While the effects of categorical variables on survival were examined by Kaplan Meier and Log Rank (Mantel-Cox) methods, Cox-Regression analysis was used for numerical variables. All Hypothesis tests were appliedat 0.05 significance level.
Results: Of the 1530 melanoma cases, 53.1% were male and 46.9% were female. The average age was 54.14 ± 16.537. Superficial spreading melanoma and lentigo malignant melanoma were the most common subtypes.11.6% of the melanoma lesions were in situ, 43.6% were localized, 6.7% were locally spread, 16.9% were regionally spread, 21.1% were advanced. The follow-up period of the patients ranged from 0 to 313 months. The mean survival time was 147.4 ± 5.3 months. The survival rate decreased with increasing age (p <0.01). The duration of survival was higher in women than in men (p< 0,001).
Conclusions: In our study, older age at diagnosis, male gender, not having in situ tumor, lymph node involvement and presence of metastasis are factors that decrease survival. Five-year survival is shorter in nodular melanoma than other histopathological subtypes. Five-year survivals were; 90% in localized disease, 52% in local spread, 56% in regional spread, 15% in advanced metastatic disease. Early diagnosis affects prognosis in cutaneous melanoma. For this reason, it is important to raise awareness of the society and ensure that patients apply earlier.
Keywords
Kaynakça
- Garbe C, Bauer J. Melanoma. In: Bolognia JL, Schaffer JV, Cerroni L (eds). Dermatology. 4th ed. China: Elsevier; 2018:1989-2019.
- Carr S, Smith C, Wernberg J. Epidemiology and Risk Factors of Melanoma. Surg Clin North Am 2020;100(1):1-12.
- Elçin G, Çakır A. Malign melanom epidemiyolojisi ve risk faktörleri. Demirci U, editör. Cilt Kanserleri. 1. Baskı. Ankara: Türkiye Klinikleri; 2019:5-11.
- Garbe C, Amaral T, Peris K, et al. European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019. Eur J Cancer2020;126:141-58.
- Garbe C, Amaral T, Peris K, et al. European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019. Eur J Cancer 2020;126:159-77.
- Ribero S, Glass D, Bataille V. Geneticepidemiology of melanoma. Eur J Dermatol. 2016;26(4):335-9.
- Siegel RL, Miller KD, Jemal A. Cancerstatistics, 2020. CA Cancer J Clin. 2020;70(1):7-30.
- Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. InVivo. 2014;28(6):1005-11.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Ayda Acar
*
Türkiye
Ayşe Hande Yoldaş
0000-0002-2219-5422
Türkiye
Banu Yaman
0000-0002-2915-0788
Türkiye
Can Ceylan
0000-0001-6528-0566
Türkiye
Şaziye Burçak Karaca
0000-0003-2638-1625
Türkiye
Mustafa Esassolak
0000-0001-7512-8015
Türkiye
Taner Akalın
0000-0003-0785-0430
Türkiye
Tahir Gürler
0000-0002-7544-3565
Türkiye
Fezal Özdemir
0000-0001-8511-4565
Türkiye
Gülşen Kandiloğlu
0000-0003-1861-1240
Türkiye
Ayfer Haydaroğlu
0000-0001-5709-0981
Türkiye
Ayşe Caner
0000-0003-3058-9971
Türkiye
Işıl Karaarslan
0000-0001-5348-027X
Türkiye
Yayımlanma Tarihi
26 Ekim 2020
Gönderilme Tarihi
28 Ağustos 2020
Kabul Tarihi
5 Ekim 2020
Yayımlandığı Sayı
Yıl 1970